Home > News > Pearls for Secondary Intraocular Lens Implantation
Anterior Segment, Corneal Disorders
Read Time: 2 mins

Pearls for Secondary Intraocular Lens Implantation

Published Online: February 23rd 2017 US Ophthalmic Review, 2017;10(1):13–4 DOI: https://doi.org/10.17925/USOR.2017.10.01.13
Authors: Marjan Farid
Quick Links:
Abstract
Article
Article Information
Abstract:
Overview

Gaining expertise in a number of surgical approaches to secondary intraocular lens (IOL) implantation allows retina specialists to tailor the procedure to the patient. In this expert interview, Marjan Farid of Gavin Herbert Eye Institute shares some tips for the optimal use of surgical techniques, including iris fixation suture lens implantation, intrascleral fixation of posterior chamber IOLs and anterior chamber lens implantation.

Keywords

Secondary intraocular lens implantation, intrascleral fixation, posterior chamber, anterior chamber

Article:

The role of secondary intraocular lens (IOL) implantation has evolved. Following advances in cataract surgery, surgical aphakia is becoming uncommon, and secondary IOL implantation is now most commonly performed as part of an IOL exchange procedure. A number of techniques and IOLs are available for secondary IOL implantation, and debate persists regarding which methods are best for eyes lacking sufficient capsular support. It is therefore important to consider specific techniques, choice of IOL, sutures, and medication regimens, in order to tailor the approach to the individual patient. In an expert interview, Marjan Farid of Gavin Herbert Eye Institute discusses the optimal use of some of the most widely used techniques.

Q: What are the advantages and disadvantages of iris fixation suture lens implantation in aphakic eyes?
The main advantages to iris-fixated IOLs as a secondary lens option are that they can be performed through a small cataract-sized clear corneal incision and do not require conjunctival or scleral surgery. Standard foldable three-piece IOLs are the preferred lens option in these cases as one-piece acrylic IOLs cannot be used for iris fixation, since they can cause iris chafing. This technique does, however, require normal iris anatomy. The disadvantages to this technique are the potential for pupil ovaling if the sutures are not placed peripheral enough. Furthermore, since manipulation of the iris is required, the risk of uveal irritation and cystoid macular edema (CME) are present.

Q: What surgical techniques can minimize complications in the implantation of iris fixation suture lenses?
In order to perform iris-fixated IOLs, certain instrumentation is required and will greatly improve the chances of success. A set of hooks to manipulate the IOL and iris (such as Lester or Kuglen hooks), small incision forceps and scissors, and a heavy molecular weight viscoelastic are essential. A combined cohesive and dispersive ophthalmic viscoelastic device (OVD) is my preferred viscoelastic for these cases as it provides excellent endothelial protection, pushes the iris down and drapes it over the haptic well, and is easy to wash out at the end of the case. A 10-0 prolene suture on a long curved CTC needle is used to hook and capture the iris/haptic as peripheral as possible to minimize pupil ovaling, and a Siepser knot technique will create a tight fixation of the iris to the haptic.

Q: In what situations should intrascleral fixation of posterior chamber IOL be considered?
In cases where there is poor iris anatomy or absolutely no capsular remnants to support the IOL during the manipulation required for iris fixation, I will choose to perform a scleral fixated secondary IOL technique. In most cases, a trans-scleral tunnel glue-fixated posterior chamber IOL will be the preferred method as this method too can be performed through a small clear corneal incision.

Q: When should an anterior chamber lens be considered?
In cases where the patient’s age is high and there is absolutely no evidence of corneal compromise or decline, a well-fitted anterior chamber IOL can provide excellent outcomes.

Article Information:
Disclosure

Marjan Farid has no conflicts of interest to declare. No funding was received in the publication of this article. This is an expert interview piece and as such has not undergone the journal’s standard peer review process.

Correspondence

Marjan Farid, MD, University of California-Irvine, Gavin Herbert Eye Institute, 850 Health Sciences Road, Irvine, CA 9269, US. E: mfarid@uci.edu

Access

This article is published under the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, adaptation, and reproduction provided the original author(s) and source are given appropriate credit.

Received

2017-02-06T00:00:00

Further Resources

Share this Article
Related Content In Corneal Disorders
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72